Budget Pressures Are Hampering Science Efforts, FDA And NIH Heads Say
This article was originally published in The Gray Sheet
The series of short-term federal budget resolutions and spending reductions are beginning to hamper scientific activities at FDA and NIH, agency heads complained last week.
You may also be interested in...
The Obama administration's $329 million in requested 2012 appropriations for FDA's device center would fund special projects, including a national device registry surveillance system and technologies to respond to biological and nuclear emergencies.
As Bharat Biotech prepares its COVID-19 vaccine for a launch in the quarter ending next 30 September and claims at least 60% efficacy, questions arise over why trials were not temporarily halted following a serious adverse event during Phase I and why this wasn’t disclosed to participants in subsequent studies.
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.